ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.325,58
0,77%
S&P 500
5.447,87
-0,31%
Dow Jones
39.411,21
0,67%
Euro vs US Dollar
1,07438
0,11%
Bitcoin
61.077,78
1,35%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Aspira Womans Health Inc (AWH)

  7. Aspira Womans Health Inc (AWH) News

AWH

Aspira Womans Health (AWH)

Aspira Womans Health Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:AWH
DatumZeitQuelleÜberschriftSymbolFirma
18/06/202422h13Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:AWHAspira Womans Health Inc
18/06/202422h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AWHAspira Womans Health Inc
14/06/202423h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AWHAspira Womans Health Inc
14/06/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AWHAspira Womans Health Inc
13/06/202414h00GlobeNewswire Inc.Aspira Women’s Health Provides Commercial, Reimbursement and Cash Guidance UpdatesNASDAQ:AWHAspira Womans Health Inc
07/06/202423h19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AWHAspira Womans Health Inc
16/05/202414h00GlobeNewswire Inc.Aspira Women’s Health to Present at the A.G.P. Healthcare Showcase on May 21NASDAQ:AWHAspira Womans Health Inc
15/05/202422h02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AWHAspira Womans Health Inc
15/05/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AWHAspira Womans Health Inc
15/05/202413h30GlobeNewswire Inc.Aspira Women’s Health Reports First Quarter 2024 Financial ResultsNASDAQ:AWHAspira Womans Health Inc
15/05/202401h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AWHAspira Womans Health Inc
15/05/202401h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AWHAspira Womans Health Inc
14/05/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AWHAspira Womans Health Inc
08/05/202414h47GlobeNewswire Inc.UPDATE -- Aspira Women’s Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15NASDAQ:AWHAspira Womans Health Inc
08/05/202414h00GlobeNewswire Inc.Aspira Women’s Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15NASDAQ:AWHAspira Womans Health Inc
07/05/202414h00GlobeNewswire Inc.Aspira Women’s Health Announces Publication of Two OvaWatch Peer-Reviewed ManuscriptsNASDAQ:AWHAspira Womans Health Inc
07/05/202400h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AWHAspira Womans Health Inc
02/05/202414h00GlobeNewswire Inc.Aspira Women’s Health Enhances its Commercial Offering with the Formal Launch of Longitudinal Monitoring Feature of OvaWatchNASDAQ:AWHAspira Womans Health Inc
09/04/202414h00GlobeNewswire Inc.Aspira Women’s Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in CaliforniaNASDAQ:AWHAspira Womans Health Inc
28/03/202412h30GlobeNewswire Inc.Aspira Women’s Health Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:AWHAspira Womans Health Inc
25/03/202413h00GlobeNewswire Inc.Aspira Women’s Health Announces New Time for its Fourth Quarter and 2023 Year End Earnings Results and CallNASDAQ:AWHAspira Womans Health Inc
21/03/202413h00GlobeNewswire Inc.Aspira Women’s Health to Present at the MedInvest Biotech & Pharma Investor ConferenceNASDAQ:AWHAspira Womans Health Inc
18/03/202413h00GlobeNewswire Inc.Aspira Women’s Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D. as PresidentNASDAQ:AWHAspira Womans Health Inc
11/03/202413h00GlobeNewswire Inc.Aspira Women’s Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024NASDAQ:AWHAspira Womans Health Inc
22/02/202414h30GlobeNewswire Inc.Aspira Women’s Health to Present at The Cancer Advocacy Group of Louisiana’s 3rd Annual NeauxCancer ConferenceNASDAQ:AWHAspira Womans Health Inc
20/02/202414h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AWHAspira Womans Health Inc
15/02/202402h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AWHAspira Womans Health Inc
15/02/202402h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AWHAspira Womans Health Inc
12/02/202414h00GlobeNewswire Inc.Aspira Women’s Health Announces Late-Breaking Poster Presentation at the Upcoming 71st Annual Scientific Meeting for the Society for Reproductive Investigation (SRI)NASDAQ:AWHAspira Womans Health Inc
07/02/202422h21Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:AWHAspira Womans Health Inc
 Showing the most relevant articles for your search:NASDAQ:AWH

Kürzlich von Ihnen besucht

NYSE
GEN
Genesis Healthcare
LSE
HIEM
Hsbc Msci Em Is
AMEX
FUSI
American Century Multise...
BIT
P1UWI6
NLBNPIT1UWI6 20991231 16...
NASDAQ
AAZBKXX
Barclays Bank Plc Autoca...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten